These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

856 related articles for article (PubMed ID: 28693523)

  • 1. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
    Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
    J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of miR-99a is associated with poor prognosis of acute myeloid leukemia and promotes myeloid leukemia cell expansion.
    Si X; Zhang X; Hao X; Li Y; Chen Z; Ding Y; Shi H; Bai J; Gao Y; Cheng T; Yang FC; Zhou Y
    Oncotarget; 2016 Nov; 7(47):78095-78109. PubMed ID: 27801668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
    Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
    BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LIN28B Activation by PRL-3 Promotes Leukemogenesis and a Stem Cell-like Transcriptional Program in AML.
    Zhou J; Chan ZL; Bi C; Lu X; Chong PS; Chooi JY; Cheong LL; Liu SC; Ching YQ; Zhou Y; Osato M; Tan TZ; Ng CH; Ng SB; Wang S; Zeng Q; Chng WJ
    Mol Cancer Res; 2017 Mar; 15(3):294-303. PubMed ID: 28011885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.
    De Luca L; Trino S; Laurenzana I; Tagliaferri D; Falco G; Grieco V; Bianchino G; Nozza F; Campia V; D'Alessio F; La Rocca F; Caivano A; Villani O; Cilloni D; Musto P; Del Vecchio L
    Cell Death Dis; 2017 Jun; 8(6):e2849. PubMed ID: 28569789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin.
    Han Y; Ye A; Zhang Y; Cai Z; Wang W; Sun L; Jiang S; Wu J; Yu K; Zhang S
    PLoS One; 2015; 10(8):e0136484. PubMed ID: 26308531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cells.
    Kawabata KC; Zong H; Meydan C; Wyman S; Wouters BJ; Sugita M; Goswami S; Albert M; Yip W; Roboz GJ; Chen Z; Delwel R; Carroll M; Mason CE; Melnick A; Guzman ML
    Blood; 2021 Feb; 137(6):812-825. PubMed ID: 32911532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-catenin/LIN28B promotes the proliferation of human choriocarcinoma cells via Let-7a repression.
    Wu J; Feng X; Du Y; Luan B; Yu H; Yu Y; Wu L; Zhao H
    Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):455-462. PubMed ID: 30958882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia.
    Liu B; Ma H; Liu Q; Xiao Y; Pan S; Zhou H; Jia L
    J Exp Clin Cancer Res; 2019 May; 38(1):200. PubMed ID: 31097000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.
    Chen C; Bai L; Cao F; Wang S; He H; Song M; Chen H; Liu Y; Guo J; Si Q; Pan Y; Zhu R; Chuang TH; Xiang R; Luo Y
    Oncogene; 2019 Jun; 38(23):4527-4539. PubMed ID: 30742065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia.
    Chen Y; Jacamo R; Konopleva M; Garzon R; Croce C; Andreeff M
    J Clin Invest; 2013 Jun; 123(6):2395-407. PubMed ID: 23676502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
    Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
    Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-582-3p negatively regulates cell proliferation and cell cycle progression in acute myeloid leukemia by targeting cyclin B2.
    Li H; Tian X; Wang P; Huang M; Xu R; Nie T
    Cell Mol Biol Lett; 2019; 24():66. PubMed ID: 31844417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation.
    Tarighat SS; Santhanam R; Frankhouser D; Radomska HS; Lai H; Anghelina M; Wang H; Huang X; Alinari L; Walker A; Caligiuri MA; Croce CM; Li L; Garzon R; Li C; Baiocchi RA; Marcucci G
    Leukemia; 2016 Apr; 30(4):789-99. PubMed ID: 26536822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACER3 supports development of acute myeloid leukemia.
    Chen C; Yin Y; Li C; Chen J; Xie J; Lu Z; Li M; Wang Y; Zhang CC
    Biochem Biophys Res Commun; 2016 Sep; 478(1):33-38. PubMed ID: 27470583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-1246-containing extracellular vesicles from acute myeloid leukemia cells promote the survival of leukemia stem cells via the LRIG1-meditated STAT3 pathway.
    Chen L; Guo Z; Zhou Y; Ni J; Zhu J; Fan X; Chen X; Liu Y; Li Z; Zhou H
    Aging (Albany NY); 2021 Apr; 13(10):13644-13662. PubMed ID: 33893245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of Ars2 inhibits cell proliferation and leukemogenesis in acute myeloid leukemia by modulating the miR-6734-3p/p27 axis.
    Hu X; Xu S; Chen Y; Gao Z; Li Y; Hu J; Huang X; Zhang Y; Jiang X; Li L; Yang C; Chen J; Gao N
    Leukemia; 2019 May; 33(5):1090-1101. PubMed ID: 30518811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia.
    Zhang X; Zeng J; Zhou M; Li B; Zhang Y; Huang T; Wang L; Jia J; Chen C
    Mol Cancer; 2012 Aug; 11():56. PubMed ID: 22900969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
    Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.